Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
6
Number of overlapping holdings
21.4%
% of PBE's 28 holdings also in CANC
12.8%
% of CANC's 47 holdings also in PBE
Overlap by Weight
Sector Drift (PBE minus CANC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBE |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ILLUMINA INC | 5.6% | 3.8% | 3.8% |
|
REGENERON PHARMACEUTICALS | 3.2% | 5.4% | 3.2% |
|
INCYTE CORP | 3.1% | 4.2% | 3.1% |
|
EXELIXIS INC | 3.9% | 3.0% | 3.0% |
|
BLUEPRINT MEDICINES CORP. | 2.9% | 4.3% | 2.9% |
Position Highlights (Non-Overlapping Exposures)
PBE Overweight Relative to CANC
|
UNITED THERAPEUTICS CORP | 5.4% |
|
ALNYLAM PHARMACEUTICALS INC | 4.6% |
|
NEUROCRINE BIOSCIENCES INC | 4.2% |
|
TG THERAPEUTICS INC | 4.2% |
|
XENCOR INC | 4.1% |
|
BIOGEN IDEC INC | 4.0% |
|
NATERA INC | 3.9% |
|
VERACYTE INC | 3.7% |
|
BIOMARIN PHARMACEUTICAL INC | 3.7% |
|
VERICEL CORPORATION | 3.0% |
PBE Underweight Relative to CANC
|
GILEAD SCIENCES INC | -5.4% |
 |
ASTRAZENECA PLC | -5.2% |
|
REVOLUTION MEDICINES, INC. | -4.6% |
 |
ARGENX SE ADR | -4.3% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -3.3% |
|
DAIICHI SANKYO CO LTD | -3.1% |
|
MERCK & CO. INC. | -2.9% |
|
AGIOS PHARMACEUTICALS INC | -2.9% |
|
BEIGENE LTD. SPONSORED ADR | -2.5% |
|
CRISPR THERAPEUTICS AG | -2.5% |